Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies.
Nur Aizati Athirah DaudJorieke E H BergmanMonika P OktoraWilhelmina S Kerstjens-FrederikseHenk GroenJens H BosEelko HakBob WilffertPublished in: PloS one (2017)
Some of the drugs which are substrates or inhibitors of placental transporters were commonly used during pregnancy. No significant effect of transporter inhibition was found on fetal drug exposure, possibly due to a limited number of exposures.